Check Before You Invest : Health X Platform Ltd

BSE: 533259 NSE: HEALTHX ISIN: INE019J01013

| Sector: BFSI | Industry: Finance - NBFC

Snapshot

Q.1 Which industry/sub-sector does Health X Platform Ltd belong to?

Health X Platform Ltd belongs to the BFSI sector, operating specifically within the Finance - NBFC segment.

Q.2 Is Health X Platform Ltd a good quality company?

Health X Platform Ltd is a weak quality company, based on a inconsistent 6-year financial track record.

Q.3 Is Health X Platform Ltd undervalued or overvalued?

Health X Platform Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Health X Platform Ltd a good buy now?

Health X Platform Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Total Income growth of Health X Platform Ltd?

Health X Platform Ltd Operating Income growth is NA% for FY-2025, which is below its 5-year CAGR of 109.13%, indicating slower growth.

Q.2 Return on Assets of Health X Platform Ltd?

Health X Platform Ltd Return on Asset is -0.3%, which is below its 5-year historical median of -0.1%, indicating deteriorated earnings on assets.

	Current Level	5-year Historic Median
NPM%	-176.66	26.02
PPOP%	-	-
RoA%	-0.3	-0.1

Q.3 Return on Equity (ROE) of Health X Platform Ltd?

Health X Platform Ltd Return on Equity is -0.3% for FY-2025, which is below its 5-year historical median of -0.1%, indicating the business is making worse use of its shareholders capital.

Q.4 Net Profit Margin of Health X Platform Ltd?

Health X Platform Ltd Net Profit Margin, which is the difference between the rate of interest earned on assets and the rate of interest paid on liabilities, is -176.66% for FY-2025, which is below its 5-year median( 26.02%), indicating decreasing margins.

Q.5 Total Asset growth of Health X Platform Ltd?

Health X Platform Ltd Total Asset growth is -0.37% for FY-2025, which is below its 5-year CAGR of -0.15%, indicating slower growth.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Health X Platform Ltd?

Promoters hold 74.84% of the Health X Platform Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 AUM Growth of Health X Platform Ltd vs Industry Peers?

Health X Platform Ltd AUM CAGR is -0.15%, compared to the 5-year industry median CAGR of 9.9%, indicating slower growth and losing its market share.

Q.2 Profit metrics (NPM, PPOP, RoA) of Health X Platform Ltd vs industry peers

Health X Platform Ltd profit metrics are in line with the industry median level of 7.31%, indicating similar profitability compared to peers.

Profit Metrics

	Current Level	5-year Industry Median
NPM%	-176.66	15.95
PPOP%	-	4.54
RoA%	-0.3	1.45

Q.3 Operating efficiency of Health X Platform Ltd vs industry peers?

Health X Platform Ltd ROCE (-0.2) is below the industry median of (4.4); while the current ROE (-0.1) are below than the 5-year average Industry ROE (2.7). This shows that the business is positioned in the bottom quartile of the industry.

Operating Efficiency

	Current Level	5-year Industry Median
NPM%	-176.66	15.95
PPOP%	-	4.54
RoA%	-0.3	1.45
ROCE%	-0.3	4.4
ROE%	-0.3	2.7

Valuation & price assessment

Q.1 Stock return of Health X Platform Ltd over the last decade?

Over the last 9 years, the stock has delivered a CAGR of 13.5% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	13.5%	11.7%	4.5%	11.7%

Q.3 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	-	-1206.64	28.96
Price to Book	3.24	3.50	1.11
Price to Sales	2234.02	2867.17	9.10
EV to EBITDA	-1236.48	-1568.29	11.77

Q.4 Valuation ratios of Health X Platform Ltdvs historical and industry averages?

The current Price to book ratio (P/B) 3.24% is lower than its historical median of 3.50%, indicating that at the current price the stock is undervalued. However, you need a deeper analysis to make a better judgement.

Strategic outlook

Q.1 Does its ROIC exceed its WACC?

Health X Platform Ltd return on invested capital (ROIC) is -0.25% for FY-2025, is lower than its estimated weighted average cost of capital (WACC) of 14%, indicating value erosion.

Check more companies

1. Tata Invest Corp

2. Manappuram Finance

3. CreditAccess Grameen

4. IIFL Finance

5. Five Star Business

6. Edelweiss Financial

7. SBFC Finance

8. Bengal & Assam

9. MAS Financial Serv

10. Fedbank Financial

Check trending companies

1. Samvardhana Motherson International Ltd.

2. Jindal Saw Ltd.

3. Union Bank Of India

4. Lloyds Metals & Energy Ltd.

5. Astral Ltd.